• Users Online: 715
  • Home
  • Print this page
  • Email this page
Year : 2014  |  Volume : 9  |  Issue : 16  |  Page : 1493-1497

Cervical spinal cord injury: tailoring clinical trial endpoints to reflect meaningful functional improvements

1 BioAxone BioSciences, Inc., Cambridge, MA, USA
2 McGill University, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada; BioAxone BioSciences, Inc., Cambridge, MA, USA

Correspondence Address:
Lisa M Bond
Director of Scientific and Regulatory Affairs, BioAxone BioSciences, Inc., One Kendall Square, Building 200, Suite 2203, Cambridge, MA 02139, USA

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1673-5374.139470

Rights and Permissions

Cervical spinal cord injury (SCI) results in partial to full paralysis of the upper and lower extremities. Traditional primary endpoints for acute SCI clinical trials are too broad to assess functional recovery in cervical subjects, raising the possibility of false positive outcomes in trials for cervical SCI. Endpoints focused on the recovery of hand and arm control (e.g., upper extremity motor score, motor level change) show the most potential for use as primary outcomes in upcoming trials of cervical SCI. As the field moves forward, the most reliable way to ensure meaningful clinical testing in cervical subjects may be the development of a composite primary endpoint that measures both neurological recovery and functional improvement.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded436    
    Comments [Add]    
    Cited by others 3    

Recommend this journal